
Victor F Tapson MD
Critical Care Medicine, Pulmonary Vascular Medicine
Professor of Medicine, Cedars-Sinai Medical Center
Join to view full profile
8700 Beverly BlvdLos Angeles, CA 90048
Phone+1 310-967-1884
Fax+1 310-423-0120
Dr. Tapson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1986
Duke University HospitalInternship, Internal Medicine, 1982 - 1983
Drexel University College of MedicineClass of 1982
Certifications & Licensure
CA State Medical License 2013 - 2027
NC State Medical License 1982 - 2026
FL State Medical License 2014 - 2020
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2017
- CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2013, 2017
Clinical Trials
Publications & Presentations
PubMed
- Systematic review of prognostic scores and individual predictor variables for short-term mortality after acute pulmonary embolism.David Jimenez, Behnood Bikdeli, Victor Tapson, Cecilia Becattini, Lisa Moores
Pulmonology. 2026-12-01 - Biological Sex Differences in the US-CTEPH-R.Meghan M Cirulis, William R Auger, Raymond L Benza, Richard N Channick, Kelly Chin
Annals of the American Thoracic Society. 2026-04-13 - 5 citationsLarge-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: Rationale and design of the PERSEVERE randomized controlled trial.Romain Chopard, Lukas Hobohm, Stefano Barco, Sripal Bangalore, Jay Giri
American Heart Journal. 2026-04-01
Journal Articles
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Victor Tapson, Daniel A Sweeney, Richard A Mularski, Alpesh N Amin, Joanne Billings, Marie-Carmelle Elie, The New England Journal of Medicine
- Remdesivir for the Treatment of Covid-19 — Final ReportAneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsGeoffrey D Barnes, Thomas M Todoran, Victor Tapson, JAMA Network Open
Other
- Treatment of acute pulmonary embolismTapson VF
http://www.uptodate.com/contents/treatment-of-acute-pulmonary-embolism
UpToDate, Wolters Kluwer Health - 2012-12-07 - Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosisTapson VF
http://www.uptodate.com/contents/fibrinolytic-thrombolytic-therapy-in-acute-pulmonary-embolism-and-l
UpToDate, Wolters Kluwer Health - 2012-11-29
Authored Content
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsAugust 2020
- Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsAugust 2020
Press Mentions
13 Questions to Ask Your Doctor About Pulmonary EmbolismJuly 29th, 2022
Researchers Introduce First Artificial Intelligence Tool to Detect COVID-19 ProbabilityDecember 13th, 2020
Study Details First Artificial Intelligence Tool to Help Labs Rule-Out Covid-19 #ThelatestnewsDecember 11th, 2020
Grant Support
- Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) TrialTRANSLATIONAL SCIENCES, INC.2021–2025
- Prospective Investigation Of Pulmonary Embolism Dx-IiNational Heart, Lung, And Blood Institute2000–2003
Industry Relationships
- VP of Medical Affairs, Inari MedicalWorking with this novel and progressive company to help move the field of VTE treatment ahead. I continue seeing patients with pulmonary embolism at Cedars-Sinai in Los Angeles.2021 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: